Literature DB >> 30636092

Clinical features and determinants of chronicity in hepatitis E virus infection.

Shivakumar Narayanan1, Ameer Abutaleb1,2, Kenneth E Sherman3, Shyam Kottilil1.   

Abstract

Hepatitis E virus (HEV) has traditionally been associated with an acute, self-limiting hepatitis and is not known to have any chronic sequelae. HEV genotypes 1 and 2, which are human pathogens, have been associated with this self-limiting presentation, in both sporadic and epidemic settings. HEV genotype 3, which is zoonotically transmitted, is increasingly being reported as a cause of chronic infection in immunocompromised patients. These include patients with solid organ transplants, patients receiving chemotherapy for haematologic malignancies and patients infected with HIV. Chronic infection is associated with rapidly progressing liver disease and extrahepatic manifestations including neurologic disorders. We review the clinical manifestations of chronic HEV infection and discuss factors determining persistence and chronicity of HEV.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic HEV; genotype 3; hepatitis E virus

Mesh:

Substances:

Year:  2019        PMID: 30636092      PMCID: PMC6437685          DOI: 10.1111/jvh.13059

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  50 in total

1.  Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.

Authors:  Weijin Huang; Huayuan Zhang; Tim J Harrison; Shuhui Lang; Guoyong Huang; Youchun Wang
Journal:  J Med Virol       Date:  2008-05       Impact factor: 2.327

2.  Safety and efficacy of a recombinant hepatitis E vaccine.

Authors:  Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

3.  Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad.

Authors:  Masaharu Takahashi; Tsutomu Nishizawa; Akira Yoshikawa; Shin Sato; Norio Isoda; Kenichi Ido; Kentaro Sugano; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

Review 4.  Hepatitis E: an emerging infection in developed countries.

Authors:  Harry R Dalton; Richard Bendall; Samreen Ijaz; Malcolm Banks
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

5.  Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

Authors:  Nassim Kamar; Janick Selves; Jean-Michel Mansuy; Leila Ouezzani; Jean-Marie Péron; Joëlle Guitard; Olivier Cointault; Laure Esposito; Florence Abravanel; Marie Danjoux; Dominique Durand; Jean-Pierre Vinel; Jacques Izopet; Lionel Rostaing
Journal:  N Engl J Med       Date:  2008-02-21       Impact factor: 91.245

6.  Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.

Authors:  R Srivastava; R Aggarwal; M R Bhagat; A Chowdhury; S Naik
Journal:  J Viral Hepat       Date:  2008-07-28       Impact factor: 3.728

7.  Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis e.

Authors:  S Saravanabalaji; A S Tripathy; R R Dhoot; M S Chadha; A L Kakrani; V A Arankalle
Journal:  Intervirology       Date:  2009-04-28       Impact factor: 1.763

Review 8.  The role of hepatitis E virus testing in drug-induced liver injury.

Authors:  H R Dalton; H J Fellows; W Stableforth; M Joseph; P H Thurairajah; U Warshow; S Hazeldine; R Remnarace; S Ijaz; S H Hussaini; R P Bendall
Journal:  Aliment Pharmacol Ther       Date:  2007-09-07       Impact factor: 8.171

9.  Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.

Authors:  M T Shata; A Barrett; N J Shire; S F Abdelwahab; M Sobhy; E Daef; S S El-Kamary; M Hashem; R E Engle; R H Purcell; S U Emerson; G T Strickland; K E Sherman
Journal:  J Immunol Methods       Date:  2007-09-19       Impact factor: 2.303

10.  Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.

Authors:  N Kamar; J-M Mansuy; O Cointault; J Selves; F Abravanel; M Danjoux; P Otal; L Esposito; D Durand; J Izopet; L Rostaing
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

View more
  13 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 2.  Sofosbuvir in the Treatment of Hepatitis E virus Infection: A Review of in vitro and in vivo Evidence.

Authors:  Temi Lampejo
Journal:  J Clin Exp Hepatol       Date:  2022-02-22

3.  Hepatitis E in a Portuguese cohort of human immunodeficiency virus positive patients: High seroprevalence but no chronic infections.

Authors:  Rita Filipe; Beatriz Prista-Leão; André Silva-Pinto; Isabel Abreu; Rosário Serrão; Rosário Costa; Edite Guedes; Joana Sobrinho-Simões; António Sarmento; Carmo Koch; Lurdes Santos
Journal:  Health Sci Rep       Date:  2022-05-20

Review 4.  Towards the Improved Accuracy of Hepatitis E Diagnosis in Vulnerable and Target Groups: A Global Perspective on the Current State of Knowledge and the Implications for Practice.

Authors:  Jasminka Talapko; Tomislav Meštrović; Emina Pustijanac; Ivana Škrlec
Journal:  Healthcare (Basel)       Date:  2021-01-29

Review 5.  Advances in Hepatitis E Virus Biology and Pathogenesis.

Authors:  Shaoli Lin; Yan-Jin Zhang
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

Review 6.  Viral hepatitis in 2021: The challenges remaining and how we should tackle them.

Authors:  Rebecca Dunn; Aaron Wetten; Stuart McPherson; Mhairi C Donnelly
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

Review 7.  Hepatitis E Virus: An emerging enigmatic and underestimated pathogen.

Authors:  Yakubu Egigogo Raji; Ooi Peck Toung; Niazlin Mohd Taib; Zamberi Bin Sekawi
Journal:  Saudi J Biol Sci       Date:  2021-09-20       Impact factor: 4.219

8.  Hepatitis E virus infection in a patient with alcohol related chronic liver disease: a case report of acute-on-chronic liver failure.

Authors:  Anabella Fantilli; Sarah Daniela López Villa; Alina Zerega; Guadalupe Di Cola; Luis López; Maribel Wassaf Martínez; María Belén Pisano; Viviana Elizabeth Ré
Journal:  Virol J       Date:  2021-12-09       Impact factor: 4.099

9.  Noninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infection.

Authors:  Qiang Li; Chong Chen; Chenlu Huang; Wei Xu; Qiankun Hu; Liang Chen
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

10.  Effect of Sodium Chloride, Sodium Nitrite and Sodium Nitrate on the Infectivity of Hepatitis E Virus.

Authors:  Alexander Wolff; Taras Günther; Thiemo Albert; Reimar Johne
Journal:  Food Environ Virol       Date:  2020-08-27       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.